Abstract
India began its nationwide coronavirus disease 2019 (COVID-19) vaccination program on January 16, 2021, in a phased manner. In this paper, we have discussed our experience at one of the COVID-19 vaccination centers in the country and have identified a few of the major challenges and their implications. The guidelines for COVID-19 vaccination in the country were changing frequently, leading to ambiguity among the beneficiaries. Co-WIN software, used for program implementation, had some glitches, which caused dissatisfaction among the service providers and beneficiaries. Vaccine hesitancy and eagerness caused low vaccine uptake initially and overcrowding at vaccination centers later. Some of the vaccination centers had the potential to become hot spots for further spread of the virus due to insufficient infrastructure. The disparity in access to vaccines for the homeless and other vulnerable groups was another hurdle for adequate vaccination coverage. These challenges could have been addressed by pretesting the information technology platform, long-term planning with a vision for handling vaccine hesitancy and eagerness, strong communication systems, removing disparities in vaccine access, and maintaining uniformity in messages for frequently updating guidelines.
Publisher
Weston Medical Publishing
Reference16 articles.
1. Pandey A, Sah P, Moghadas SM, et al.: Challenges facing COVID-19 vaccination in India: Lessons from the initial vaccine rollout. J Glob Health. 2021; 11: 03083.
2. Choudhary OP, Choudhary P, Singh I: India’s COVID-19 vaccination drive: Key challenges and resolutions. Lancet Infect Dis. 2021; 21: 1483-1484.
3. Rackimuthu S, Hasan MM, Bardhan M, et al.: COVID-19 vaccination strategies and policies in India: The need for further re-evaluation is a pressing priority. Health Plann Manag. 2022; 37: 1847-1850.
4. Vashishtha VM, Kumar P: Responding to new challenges: Is there a need to relook and revise our COVID-19 vaccination strategy? Expert Rev Vaccines. 2022; 21: 1015-1018.
5. Ministry of Health & Family Welfare: Centre writes to states/UTs to increase the interval between two doses of Covishield to 4-8 weeks based on NTAGI and NEGVAC recommendation. Protection enhanced if the second dose of Covishield is administered between 6-8 weeks. Ministry of Health & Family Welfare, Government of India. 2021. Available at https://pib.gov.in/PressReleasePage.aspx?PRID=1706597. Accessed June 24, 2021.